[引用][C] 西妥昔治疗头颈部鳞癌的研究进展

刘得玺, 牛玉明, 罗志晓, 冷卫东 - 临床口腔医学杂志, 2015

[HTML][HTML] 替沃扎尼抑制甲状腺癌细胞和血管内皮细胞的增殖

郭丽娟, 郑岩, 刘鹏飞, 王恩彤 - 肿瘤防治研究, 2014 - zlfzyj.com
目的研究新型酪氨酸激酶抑制剂替沃扎尼对甲状腺癌细胞株SW579 和血管内皮细胞株HUVEC
增殖的影响及作用机制. 方法SW579 和HUVEC 暴露于不同浓度(1, 2, 4, 8 和16 μM) …

[引用][C] BER 通路DNA 修复基因多态性与头颈肿瘤易感性的研究进展

夏志杰, 阿依恒 - 癌症进展, 2014

Biomarkers for individualized oral cancer therapy

NJ D'Silva - Personalized Oral Health Care: From Concept Design …, 2015 - Springer
This chapter focuses on personalized medicine for oral cancer, with emphasis on selection
of current and future therapies. Specifically, treatment selection of radiation, chemotherapy …

[引用][C] 化学小分子对前列腺癌等肿瘤EGFR 受体靶向治疗的进一步认识

邱启裕, 杨嗣星, 全欣鑫 - 现代泌尿生殖肿瘤杂志, 2014

[引用][C] 帕唑帕尼对甲状腺癌细胞和血管内皮细胞增殖的影响及其作用机制

郭丽娟, 郑岩, 刘鹏飞, 王恩彤 - 中国医药, 2014

[图书][B] Effectiveness of Sulforaphane in Increasing Drug Mediated Cytotoxicity Toward Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma

O ElKashty - 2020 - search.proquest.com
Cancer is the leading cause of death in Canada with the head and neck cancer (HNC)
ranked seventh in the rate of incidence. More than 90% of HNCs are squamous cell …

Small-molecule inhibitors targeting receptor tyrosine kinases in cancer

M Hojjat-Farsangi, G Khamisipour - Pharmaceutical Biocatalysis, 2020 - taylorfrancis.com
Small molecule inhibitors of tyrosine kinase activity and monoclonal antibodies are among
the widely used drugs for targeted based cancer therapy, and bind to intracellular and cell …

[图书][B] Pharmaceutical Biocatalysis: Important Enzymes, Novel Targets, and Therapies

P Grunwald - 2020 - books.google.com
This volume of Pharmaceutical Biocatalysis starts with a discussion on the importance of
biocatalytic synthesis approaches for a sustainable and environmentally friendly production …

Checkpoint inhibitors in head and neck cancer

I Sepulveda, R Ascui, AA Capizzano - memo-Magazine of European …, 2019 - Springer
Head and neck cancer (HNC) are aggressive cancers and represents the sixth leading
cancer by incidence worldwide. This kind of cancer constitutes about 3% of all newly …